UK’s CGT Catapult Partners with Freeline to Build Gene Therapy Manufacturing Platform – Genetic Engineering & Biotechnology News
|
UK's CGT Catapult Partners with Freeline to Build Gene Therapy Manufacturing Platform
Genetic Engineering & Biotechnology News The Cell and Gene Therapy (CGT) Catapult said today it will partner with Freeline Therapeutics to build the gene therapy developer's proprietary manufacturing platform at the CGT Catapult's large-scale GMP manufacturing center in Stevenage … |
